Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache
NCT07714369
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Cluster Headache
Interventions
DRUG:
Zavegepant 20 mg
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
[object Object]